Search clinical trials for: non responder

Total 53416 results

University of Sao Paulo

Unknown

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients (ARIQUELI-ME)

Bipolar Disorder

Brazil
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Immune Enhancement for Immunological Non-responders to ART (IMMUNE)

HIV

United States
Indonesia University

Completed

The Role of Probiotics in HIV Patients With Immunological Non-Responder (PIONIR)

HIV Infections | Immunological Abnormality

Indonesia
Ciusss de L'Est de l'Île de Montréal

Completed

Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders (CRY-MOOD)

Major Depressive Disorder

Canada
Dartmouth-Hitchcock Medical Center

Withdrawn

A Prospective, Observational Study of the PPI Non-responder

Gastro Esophageal Reflux Disease PPI Non-Responders
Assiut University
Sohag University; South Valley University

Completed

Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure

HCV Coinfection

Egypt
Institute of Cardiology, Warsaw, Poland

Completed

CPET Predicts Long-term Survival and Positive Response to CRT (CPET-CRT)

Heart Failure With Reduced Ejection Fraction
Abbott Medical Devices

Completed

Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates (ENVISION)

Heart Failure

United States
Maastricht University Medical Center
CyTuVax

Completed

Hepatitis B Vaccine for Non-responders

Hepatitis B

Belgium, Netherlands
Maastricht University Medical Center
CyTuVax

Completed

Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders

Hepatitis B

Netherlands
Barcelona Macula Foundation
Bayer; TFS Trial Form Support

Completed

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor (MACBETH)

Wet Macular Degeneration

Spain
Merck Sharp & Dohme LLC

Completed

Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)

Hepatitis C, Chronic
West Coast Retina Medical Group, Inc.
Genentech, Inc.

Unknown

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Wet AMD

United States
University Health Network, Toronto

Completed

Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

Age Related Macular Degeneration

Canada
Hartford HealthCare

Unknown

Status Migrainosus - Differentiating Between Responders and Non-responders

Migraine

United States
King Faisal Specialist Hospital & Research Center

Terminated

Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

Carcinoma of Esophagus

Saudi Arabia
Pontificia Universidad Catolica de Chile
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Unknown

Resistance to Immunotherapy in Gastric Cancer (MERIT)

Metastatic Gastric Cancer

Chile
Universidade Nova de Lisboa

Unknown

Individual Responder Analysis of the Effectiveness of Manual Therapy and Exercise Versus Usual Care in Patients With Chronic Nonspecific Neck Pain

Chronic Nonspecific Neck Pain
Universität des Saarlandes

Completed

Optimization of Preventive Effects of Physical Training (SAusE)

Primary Prevention, Cardiovascular Risk Factor Management, Size of Response to Training

Germany
Instituto Nacional de Ciencias Medicas y Nutricion...

Unknown

Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

Primary Biliary Cirrhosis

Mexico
University Hospital Ostrava
University of Ostrava; Clínica Opcíon Médica Barcelona; Optimal Clinic Tel Aviv

Completed

Adjustable Balloons for Weight Loss: A Higher Yield of Responders Compared With Non-Adjustable Balloons

Obesity

Czechia, Israel, Spain
Amgen

Terminated

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab (ROCkIES)

Moderate to Severe Rheumatoid Arthritis

United States, Canada, Puerto Rico
University of Colorado, Denver
Denver Health Medical Center

Completed

Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population

Dravet Syndrome

United States
Medice Arzneimittel Pütter GmbH & Co KG
University Hospital Muenster

Completed

Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis (DoriPha)

Pharyngitis

Germany
Santen Pharmaceutical Co., Ltd.

Completed

A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Primary Open Angle Glaucoma or Ocular Hypertension

Japan
Dave Hostler
Federal Emergency Management Administration; Eyemarker Systems, Inc

Completed

Enhanced Firefighter Rehab Trial: The Role of Aspirin in Preventing Heat Stress Induced Platelet Activation (EFFoRT)

Heat Stress Disorders

United States
University of California, Davis

Completed

Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI) (PANPI)

Erectile Dysfunction
University of Rome Tor Vergata

Completed

Effects of Multipoint Pacing CRT-D on Neurohormonal Activation.

Heart Failure

Italy
Cairo University

Unknown

Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol

Invitro Fertilization

Egypt
Beth Israel Deaconess Medical Center
Schering-Plough

Completed

Study of Long-term Peg Intron vs. Colchicine in Non-responders. (COPILOT)

Cirrhosis | Hepatitis C Virus | Advanced Fibrosis

United States
Zealand University Hospital

Terminated

RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders (RISCLON)

Stroke

Denmark
GlaxoSmithKline

Completed

Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y

Hepatitis B
Novartis

Completed

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients

Hypertension

Germany, United States
University of Utah
AlzChem, LLC

Completed

Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram

Major Depressive Disorder

United States
Medtronic Bakken Research Center
Medtronic; FRANCE

Completed

Dual-Site LV Pacing in CRT Non Responders: Multicenter Randomized Trial (V3)

Heart Failure

France
Medical University of Vienna

Completed

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (NRSily)

Hepatitis C

Austria
Pfizer

Completed

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Hepatitis, Chronic Active

United States
Centre Hospitalier Universitaire de Besancon

Terminated

Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment (BIOVRAIE)

Plantar Warts
Hospital Clinic of Barcelona
Abbott

Unknown

(MitraClip in Non-Responders to Cardiac Resynchronization Therapy) (MITRA-CRT)

MITRAL REGURGITATION

Spain
National Institute of Diabetes and Digestive and...
Bristol-Myers Squibb

Completed

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Hepatitis C | Hepatitis C, Chronic | Cirrhosis | Chronic Hepatitis C

United States
Novartis

Completed

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients

Hypertension

United States, Germany
Maja Kovacevic, MD

Withdrawn

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Androgenetic Alopecia | Female Pattern Hair Loss

Italy
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb

Completed

Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)

Hepatitis C Virus Genotype 4 Infection

France
Assiut University

Unknown

Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders

In Vitro Fertilization | Poor Ovarian Response

Egypt
Novartis

Completed

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

Hypertension

Sweden, Slovakia, Argentina, Germany, Turkey, Norway, Poland
Zealand University Hospital

Completed

Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke) (NATIS)

Acute Ischemic Stroke

Denmark
Chong Kun Dang Pharmaceutical

Completed

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Hypertension

Korea, Republic of
Rikshospitalet University Hospital

Completed

PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy

Gastroesophageal Junction Cancer

Denmark
Hoffmann-La Roche

Completed

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)

Rheumatoid Arthritis

Portugal
Turkish Metabolic Surgery Foundation

Unknown

Surgical Intervention for the Treatment of Diabetes in Overweight Non-responders-1 (SIT-DOWN-1)

Diabetes Mellitus, Type 2 | Overweight

3

Subscribe